Literature DB >> 20585406

Face Fields and Microperimetry for Estimating the Location of Fixation in Eyes with Macular Disease.

Janet S Sunness1.   

Abstract

Face field evaluation provides insights into the presence and location of the preferred retinal locus, as validated by comparisons with findings from microperimetry. This technique requires no special equipment and can be used in a clinic or at a person's home by clinicians and low vision rehabilitation specialists.

Entities:  

Year:  2008        PMID： 20585406      PMCID： PMC2888307     

Source DB:  PubMed          Journal:  J Vis Impair Blind        ISSN： 0145-482X


  22 in total

1.  Effects of preferred retinal locus placement on text navigation and development of advantageous trained retinal locus.

Authors:  Gale R Watson; Ronald A Schuchard; William R De l'Aune; Erica Watkins
Journal:  J Rehabil Res Dev       Date:  2006 Sep-Oct

2.  Static fundus perimetry using the scanning laser ophthalmoscope with an automated threshold strategy.

Authors:  K Rohrschneider; T Fendrich; M Becker; H Krastel; F E Kruse; H E Völcker
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-12       Impact factor: 3.117

3.  Preferred retinal locus development in patients with macular disease.

Authors:  Michael D Crossland; Louise E Culham; Stamatina A Kabanarou; Gary S Rubin
Journal:  Ophthalmology       Date:  2005-09       Impact factor: 12.079

4.  Asymmetry of the effective visual field in reading.

Authors:  K Rayner; A D Well; A Pollatsek
Journal:  Percept Psychophys       Date:  1980-06

5.  Combined use of several preferred retinal loci in patients with macular disorders when reading single words.

Authors:  F Duret; M Issenhuth; A B Safran
Journal:  Vision Res       Date:  1999-02       Impact factor: 1.886

6.  Reading with simulated scotomas: attending to the right is better than attending to the left.

Authors:  E M Fine; G S Rubin
Journal:  Vision Res       Date:  1999-03       Impact factor: 1.886

7.  Using two preferred retinal loci for different lighting conditions in patients with central scotomas.

Authors:  H Lei; R A Schuchard
Journal:  Invest Ophthalmol Vis Sci       Date:  1997-08       Impact factor: 4.799

8.  The oculomotor reference in humans with bilateral macular disease.

Authors:  J M White; H E Bedell
Journal:  Invest Ophthalmol Vis Sci       Date:  1990-06       Impact factor: 4.799

9.  Scanning laser ophthalmoscopic analysis of the pattern of visual loss in age-related geographic atrophy of the macula.

Authors:  J S Sunness; N M Bressler; M G Maguire
Journal:  Am J Ophthalmol       Date:  1995-02       Impact factor: 5.258

10.  Validity and interpretation of Amsler grid reports.

Authors:  R A Schuchard
Journal:  Arch Ophthalmol       Date:  1993-06
View more
  4 in total

1.  Progression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16.

Authors:  Tiarnan D Keenan; Elvira Agrón; Amitha Domalpally; Traci E Clemons; Freekje van Asten; Wai T Wong; Ronald G Danis; SriniVas Sadda; Philip J Rosenfeld; Michael L Klein; Rinki Ratnapriya; Anand Swaroop; Frederick L Ferris; Emily Y Chew
Journal:  Ophthalmology       Date:  2018-07-27       Impact factor: 12.079

2.  Age-Related Macular Degeneration: Epidemiology and Clinical Aspects.

Authors:  Tiarnán D L Keenan; Catherine A Cukras; Emily Y Chew
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Prediction of visual function from automatically quantified optical coherence tomography biomarkers in patients with geographic atrophy using machine learning.

Authors:  Konstantinos Balaskas; S Glinton; T D L Keenan; L Faes; B Liefers; G Zhang; N Pontikos; R Struyven; S K Wagner; A McKeown; P J Patel; P A Keane; D J Fu
Journal:  Sci Rep       Date:  2022-09-16       Impact factor: 4.996

Review 4.  Mechanisms of protection of retinal pigment epithelial cells from oxidant injury by humanin and other mitochondrial-derived peptides: Implications for age-related macular degeneration.

Authors:  Parameswaran G Sreekumar; Ram Kannan
Journal:  Redox Biol       Date:  2020-07-29       Impact factor: 11.799
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.